Development of a bioconjugations for carrying the MT29 molecule for the treatment ...
Development of the miR-29c (miR-MT29) for the treatment of skeletal muscle atrophy
Development of the miR-29c (miR-MT29) for the treatment of skeletal muscle atrophy
Role of tumor-derived microRNAs in inducing muscle mass loss in patients with Canc...
MOLECULAR, TRANSCRIPTOMIC, PROTEOMIC AND METABOLOMIC ASPECTS OF CAQUEXIA IN A PRE-...
Superexpression of miR-29c as a potential treatment of skeletal muscular atrophy i...
Genomic profiling of messenger RNAs and microRNAs in muscle cells treated in vitro...